`
`AO 120 (Rev. 08/10}
`
`TO:
`
`Mail Step 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1458
`Alexandria, VA 22313-1456
`
`|
`
`REPORTON THE
`FOULING GR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`fn Compliance with 35 U.S.C. § 290 and/or 15 ULS.C. § 1116 you are hereby advisedthat a court action has been
`of the District of Delaware on the following
`
`filed in the U.S. District Court
`[_] Trademarks or
`ff Patents.
`the patent action involves 35 U.S.C. § 292.):
`¢
`([]
`
`DOCKET NO.
`4
`
`PLAINTIPF
`
`DATE FILED
`5/3/2018
`
`U.S. DISTRICT COURT
`of the District of Delaware
`
`[DEFENDANT
`
`NOVEN PHARMACEUTICALS, INC.
`
`: AMNEAL PHARMACEUTICALS LLC
`
`PATENT OR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`.
`.
`ae
`HOLDER OF PATENT OR TRADEMARK
`
`9,730,900
`
`9,724,310
`
`9,833,419
`
`8/15/2017
`
`Noven Pharmaceuticals, Inc.
`
`8/8/2047
`
`Noven Pharmaceuticals, inc.
`
`12/5/2017
`
`CX Answer
`
`[i] Cross Bill
`
`[| Other Pleading
`
`Noven Pharmaceuticals, inc.
`Noven Pharmaceuticais, Inc.
`(BY) DEPUTY CLERK
`
`In the above—entitled case, the following patent(s)/ trademark(s) have been inciuded:
`INCLUDED BY
`Li] Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`DATE NSRP
`ee!
`PATENTOR
`TRADEMARK NO.
`
`HOLDER OF PATENT OR TRADEMARK
`
`{n the above-—entitled case, the following decision has been rendered or judgement issued:
`DECTISIONJUDGEMENT
`
`Copy 1-—Upon initiation of action, mail this copy to Director Cepy 3-—-Upon termination of action, mail this copy te Director
`Copy 2--Upen Ming document adding patent(s), mail this copy te Director Cepy 4—Case fle copy
`
`